摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Pd(2,2'-bipyrimidine)Cl2 | 105083-99-6

中文名称
——
中文别名
——
英文名称
Pd(2,2'-bipyrimidine)Cl2
英文别名
Pd(bpm)Cl2;[Pd(2,2'-bipyrimidine)Cl2];[PdCl2(bispyrimidine)]
Pd(2,2'-bipyrimidine)Cl<sub>2</sub>化学式
CAS
105083-99-6
化学式
C8H6Cl2N4Pd
mdl
——
分子量
335.488
InChiKey
RJTWDSSKRTZPEV-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

点击查看最新优质反应信息

文献信息

  • Pyrazolato- and 3,5-Dimethylpyrazolato-Bridged Dinuclear Platinum(II), Palladium(II), and Their Mixed-Metal Complexes of 2,2′-Bipyrimidine. Syntheses, Structures, and Luminescent Properties
    作者:Keisuke Umakoshi、Kazutoyo Kimura、Yong Hun Kim、Yuya Tsukimoto、Yasuhiro Arikawa、Masayoshi Onishi、Shoji Ishizaka、Noboru Kitamura
    DOI:10.1246/bcsj.20100208
    日期:2010.12.15
    The pyrazolato (pz)- and 3,5-dimethylpyrazolato (Me2pz)-bridged dinuclear platinum(II) and palladium(II) complexes of 2,2′-bipyrimidine (bpym), [Pt2(bpym)2(μ-pz′)2](PF6)2 (pz′ = pz (1a) and Me2pz (1b)) and [Pd2(bpym)2(μ-pz′)2](PF6)2 (pz′ = pz (2a) and Me2pz (2b)), have been synthesized and structurally characterized. The Pd–Pt complex, [PdPt(bpym)2(μ-Me2pz)2](PF6)2 (4b), has also been synthesized and characterized by 1H NMR spectroscopy. Among these Pt2, Pd2, and PdPt complexes, only 1a and 1b exhibit greenish blue and yellow-green luminescence, respectively, in the solid state at ambient temperature. The emissions of 1a and 1b in the solid state are tentatively assigned as the emission from the 3LC/MLCT and 3MMLCT excited states, respectively.
    合成并结构表征了桥接的吡唑(pz)和3,5-二甲基吡唑(Me2pz)二核(II)和(II)复合物2,2'-联吡啶(bpym)[Pt2(bpym)2(μ-pz′)2](PF6)2(pz′ = pz (1a)和Me2pz (1b))以及[Pd2(bpym)2(μ-pz′)2](PF6)2(pz′ = pz (2a)和Me2pz (2b))。此外,合成并通过1H NMR光谱表征了-复合物[复式: [PdPt(bpym)2(μ-Me2pz)2](PF6)2 (4b)。在这些Pt2、Pd2和PdPt复合物中,只有1a和1b在常温固态下分别表现出绿蓝色和黄绿色的发射。1a和1b在固态下的发射暂时被指定为来自3LC/MLCT和3MMLCT激发态的发射。
  • Solution and solid state coexistence of head–head and head–tail isomers in dimeric Pd(<scp>ii</scp>) and Pt(<scp>ii</scp>) complexes of the type [M<sub>2</sub>(a–a)<sub>2</sub>(µ-L-N<sup>3</sup>N<sup>4</sup>)<sub>2</sub>]<sup>2+</sup>with a bridging triazolopyrimidine ligand and chelating bidentate diamines
    作者:Mohammad Abul Haj、Miguel Quirós、Juan M. Salas
    DOI:10.1039/b207263g
    日期:——
    Six palladium and one platinum compound containing dimeric dinuclear cations of the type [M2(a–a)2(µ-7tpO-N3,N4)2]2+ are presented, a–a representing a bidentate chelating amine and 7tpO− being the anionic form of the ligand 4,7-dihydro-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine, which bridges the metal atoms through its nitrogen atoms in positions 3 and 4. Two linkage isomers are possible for such complexes, so called head–head and head–tail. According to 1H- and 195Pt-NMR data, both isomers are present in dmso-d6 solution and display analogous stability. An exhaustive assignment of the 1H signals has been made. The crystal structure of three of these compounds has been determined by single-crystal X-ray diffraction. For two of them, those with bispyrimidine as auxiliary ligand, the head–head and head–tail isomers coexist even in the solid state, both being present in the same crystal in a disordered scheme. This situation is explained by the almost symmetric external shape of the bridging ligand, which is expected to interact with neighbouring species in a similar way even if rotated 180 degrees.
    本文介绍了六种化合物和一种化合物,它们含有类型为 [M2(a–a)2(µ-7tpO-N3,N4)2]²⁺ 的二聚体双核阳离子,其中 a–a 代表一种双齿配位胺,7tpO⁻ 是配体 4,7-二氢-7-氧代[1,2,4]三唑[1,5-a]嘧啶的阴离子形式,该配体通过其在 3 位和 4 位的氮原子连接属原子。这种配合物可能存在两种链接异构体,称为头-头和头-尾。根据 1H 和 195Pt-NMR 数据,这两种异构体均存在于 DMSO-d6 溶液中,并显示出类似的稳定性。对 1H 信号进行了详尽的归属。通过单晶 X 射线衍射法确定了其中三种化合物的晶体结构。对于其中两种化合物,即以双嘧啶作为辅助配体的那两种,头-头和头-尾异构体甚至在固态下也共存,二者均存在于同一晶体中,呈现无序结构。这种情况可以用桥接配体几乎对称的外部形状来解释,即使旋转 180 度,该配体预计也会以类似的方式与相邻物种相互作用。
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)